Gene therapy player Spark eyes a groundbreaking approval by 2017

Damian Garde

Therapeutics, at work on therapies for rare diseases, laid out an ambitious three-year plan that would see its top candidate win FDA and 9 others enter clinical trials.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS